Tamsulosin-d4 (hydrochloride)

Confirm delete?

Tamsulosin-d₄ (hydrochloride)

Zoom

Cat No: 28486

Biochemicals - Isotopically Labeled Standards

Tamsulosin-d4 is intended for use as an internal standard for the quantification of tamsulosin (Item No. 24020) by GC- or LC-MS. Tamsulosin is a potent antagonist of α1-adrenergic receptors (α1-ARs; Ki = 0.229 nM in a radioligand binding assay).{36342...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl-1,1,2,2-d4]amino]propyl]-2-methoxy-benzenesulfonamide, monohydrochloride

Correlated keywords:

1231943-97-7 deuterated deuterium LY253351 YM-12617-1 106133-20-4 112101-78-7 128332-25-2 LY-2353351 YM12617 dynapress flomax harnal omic omnic urimax uripro YM-617 YM617 yutanal 2 ?1AR ?2AR pA-2 F-2? PGF2? d-4 GCMS LCMS

Product Overview:
Tamsulosin-d4 is intended for use as an internal standard for the quantification of tamsulosin (Item No. 24020) by GC- or LC-MS. Tamsulosin is a potent antagonist of α1-adrenergic receptors (α1-ARs; Ki = 0.229 nM in a radioligand binding assay).{36342} It is 3,800-fold selective for α1-ARs over α2-ARs (Ki = 871 nM). Tamsulosin antagonizes norepinephrine-induced contraction of isolated rabbit aorta (pA2 = 10.11) but has no effect on contraction stimulated by histamine, serotonin (Item No. 14332), angiotensin II (Item No. 17150), or prostaglandin F2α (Item No. 16010). In vivo, tamsulosin reverses the pressor effect of phenylephrine (Item Nos. 17205
18619) in pithed rats. It reversibly reduces fertility in male rats when administered at a dose of 0.15 mg/kg.{36343} Tamsulosin (1-100 μg/kg) also reduces prostatic pressure in a dose-dependent manner with minimal hypotensive effects in anesthetized dogs.{36344} Formulations containing tamsulosin have been used in the treatment of benign prostatic hyperplasia.

Size	2.5 mg
Shipping	dry ice
Molecular Formula	C₂₀H₂₄D₄N₂O₅S • HCl
SMILES	COC1=CC=C(C[C@@H](C)NC([2H])([2H])C([2H])([2H])OC2=CC=CC=C2OCC)C=C1S(N)(=O)=O.Cl
Molecular Weight	449
Formulation	A solid
Purity	≥99% deuterated forms (d1-d4)
Custom Code	3822.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.